Crestor (Rosuvastatin) is a once-daily prescription medication for use as an adjunct to diet in the treatment of various lipid disorders including primary hypercholesterolemia, mixed dyslipidemia and isolated hypertriglyceridemia. It is a member of the statin (HMG-CoA reductase inhibitors) class of drug therapy.
Health Canada is advising Canadians about a possible association between the cholesterol lowering drug Crestor®, and a serious condition called rhabdomyolysis.
Adults with type 2 diabetes who have just one additional risk factor for heart disease should be taking medication to lower cholesterol levels, according to new guidelines from the American College of Physicians (ACP).
Medicare has announced it will be publishishing detailed information comparing the prices of most prescription drugs, which is set to shake up the pharmaceutical industry.
The cardiovascular market, one of the most hotly contested therapeutic areas of the pharmaceutical industry, continues to expand. Together, drugs that lower blood pressure and cholesterol treat 303 million potential patients worldwide. Nevertheless, companies that develop fourth or fifth to market drugs will struggle to compete, according to research by business intelligence firm Cutting Edge Information.